Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1996-07-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.93.15.7481PMID 8755499PMCID PMC38770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.

  1996cited by this paper
• The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.

  1995cited by this paper
• Role of Glutamic Acid 988 of Human Poly-ADP-ribose Polymerase in Polymer Formation

  1995cited by this paper
• The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy.

  1995cited by this paper
• Poly(ADP-ribose) polymerase: structure-function relationship.

  1995cited by this paper
• The three-dimensional crystal structure of cholera toxin.

  1995cited by this paper
• A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage.

  1995cited by this paper
• Structure of the isolated catalytic domain of diphtheria toxin.

  1994cited by this paper
• The crystal structure of pertussis toxin.

  1994cited by this paper
• Common features of the NAD‐binding and catalytic site of ADP‐ribosylating toxins

  1994cited by this paper
• Crystallization and X-ray crystallographic analysis of recombinant chicken poly(ADP-ribose) polymerase catalytic domain produced in Sf9 insect cells.

  1994cited by this paper
• Refined structure of dimeric diphtheria toxin at 2.0 Å resolution

  1994cited by this paper
• Poly(ADP-ribose) polymerase: a molecular nick-sensor.

  1994cited by this paper
• Common structure of the catalytic sites of mammalian and bacterial toxin ADP-ribosyltransferases

  1994cited by this paper
• Identification of potential active-site residues in the human poly(ADP-ribose) polymerase.

  1993cited by this paper
• Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin.

  1993cited by this paper
• Overproduction of the poly(ADP‐ribose) polymerase DNA‐binding domain blocks alkylation‐induced DNA repair synthesis in mammalian cells.

  1993cited by this paper
• NAD(+)-dependent repair of damaged DNA by human cell extracts.

  1993cited by this paper
• Molecular and biochemical features of poly (ADP-ribose) metabolism

  1993cited by this paper
• The carboxyl-terminal domain of human poly(ADP-ribose) polymerase. Overproduction in Escherichia coli, large scale purification, and characterization.

  1993cited by this paper
• Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor.

  1992cited by this paper
• The crystal structure of diphtheria toxin

  1992cited by this paper
• Subunit assembly and active site location in the structure of glutamate dehydrogenase

  1992cited by this paper
• Free R value: a novel statistical quantity for assessing the accuracy of crystal structures

  1992cited by this paper
• Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase.

  1991cited by this paper
• Effect of PD 128763, a new potent inhibitor of poly(ADP-ribose) polymerase, on X-ray-induced cellular recovery processes in Chinese hamster V79 cells.

  1991cited by this paper
• Computer modelling of the NAD binding site of ADP‐ribosylating toxins: active‐site structure and mechanism of NAD binding

  1991cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

  1986cited by this paper
• Inhibitors of poly(ADP-ribose) synthesis enhance X-ray killing of log-phase Chinese hamster cells.

  1984cited by this paper

• Tankyrases and Their Binding Proteins: Origins of Their Roles in Diverse Cellular Pathways.

  2026cites this paper
• Oxidative Stress and Poly(ADPribosyl)ation in Zebrafish Eyes After Exposure to Aluminium

  2025cites this paper
• Poly‐ADP‐ribosylation dynamics, signaling, and analysis

  2024cites this paper
• PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer

  2024cites this paper
• The Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design.

  2024cites this paper
• Exploration of poly (ADP‐ribose) polymerase inhibitor resistance in the treatment of BRCA1/2‐mutated cancer

  2024cites this paper
• Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1

  2023cites this paper
• The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors

  2023cites this paper
• PARP molecular functions and applications of PARP inhibitors in cancer treatment

  2023cites this paper
• An overview of compound properties, multiparameter optimization, and computational drug design methods for PARP-1 inhibitor drugs.

  2023cites this paper
• Poly(ADP-Ribose) Polymerase-1 Lacking Enzymatic Activity Is Not Compatible with Mouse Development

  2023cites this paper
• Poly(ADP-ribose)polymerases 1 and 2: Classical Functions and Interaction with HPF1 ‒ New Histone Poly(ADP-ribosyl)ation Factor

  2023cites this paper
• Mono-ADP-ribosyltransferase 1 (Artc1)-deficiency decreases tumorigenesis, increases inflammation, decreases cardiac contractility, and reduces survival

  2023cites this paper
• ADP-ribosylation from molecular mechanisms to therapeutic implications

  2023cites this paper
• Characterization of an Aedes ADP-Ribosylation Protein Domain and Role of Post-Translational Modification during Chikungunya Virus Infection

  2023cites this paper
• Updated protein domain annotation of the PARP protein family sheds new light on biological function

  2023cites this paper
• The superior salinity tolerance of bread wheat cultivar Shanrong No. 3 is unlikely to be caused by elevated Ta-sro1 poly-(ADP-ribose) polymerase activity

  2022cites this paper
• Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics

  2022cites this paper
• Crystal structures of the catalytic domain of human PARP15 in complex with small molecule inhibitors.

  2022cites this paper
• PARP1: Liaison of Chromatin Remodeling and Transcription

  2022cites this paper
• Multi-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment.

  2022cites this paper
• Structural and Functional Characterization of Legionella pneumophila Effector MavL

  2021cites this paper
• Theoretical insights into molecular mechanism and energy criteria of PARP‐2 enzyme inhibition by benzimidazole analogues

  2021influential citation
• The superior salinity tolerance of wheat cultivar Shanrong No. 3 cannot be attributed to elevated Ta-sro1 poly(ADP-ribose) polymerase activity

  2021cites this paper
• PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

  2021cites this paper
• Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins

  2021cites this paper
• CmRCD1 represses flowering by directly interacting with CmBBX8 in summer chrysanthemum

  2021cites this paper
• SARM1 signaling mechanisms in the injured nervous system.

  2021cites this paper
• The PARP Way to Epigenetic Changes

  2021cites this paper
• PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1.

  2021cites this paper
• PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling

  2021cites this paper
• Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance

  2021cites this paper
• Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition

  2020cites this paper
• Modeling of the Enzyme—Substrate Complexes of Human Poly(ADP-Ribose) Polymerase 1

  2020cites this paper
• HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation

  2020cites this paper
• Progress and outlook in studying the substrate specificities of PARPs and related enzymes

  2020cites this paper
• An assessment of poly (ADP‐ribose) polymerase‐1 role in normal and cancer cells

  2020cites this paper
• Dynamics of the HD regulatory subdomain of PARP-1; substrate access and allostery in PARP activation and inhibition

  2020cites this paper
• Poly(ADP-ribose) polymerase inhibition: past, present and future

  2020cites this paper
• The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction.

  2020cites this paper
• The Development of Rucaparib/Rubraca®: A Story of the Synergy Between Science and Serendipity

  2020cites this paper
• Poly(ADP-ribose) polymerase inhibition: past, present and future

  2020cites this paper
• 1,4-dihidropiridīna atvasinājumu ietekme uz DNS reparācijas un proteolīzes enzīmu ekspresiju cukura diabēta modelī un DNS divpavedienu pārrāvumu līmeni in vitro

  2019cites this paper
• Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.

  2019cites this paper
• Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.

  2019cites this paper
• Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins

  2019cites this paper
• PARPs in genome stability and signal transduction: implications for cancer therapy

  2018cites this paper
• Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity

  2018cites this paper
• A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy

  2018cites this paper
• Double‐barreled gun: Combination of PARP inhibitor with conventional chemotherapy

  2018cites this paper
• Investigation into the relationship between PARPs in DNA repair and synthetic lethality with homologous recombination deficiency

  2017influential citation
• Physical and functional interactions of the tumor suppressor protein p53 with poly(ADP-ribose) polymerase-1 and its enzymatic product poly(ADP-ribose)

  2017cites this paper
• Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.

  2017cites this paper
• Structural modeling of NAD+ binding modes to PARP-1

  2017cites this paper
• Targeting DNA Damage Response Pathways in Cancer

  2017cites this paper
• A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy.

  2017cites this paper
• Novel PARP inhibitors sensitize human leukemic cells in an endogenous PARP activity dependent manner

  2016cites this paper
• Sirtuins are Unaffected by PARP Inhibitors Containing Planar Nicotinamide Bioisosteres

  2016cites this paper
• Structural Basis and Mechanism of Chiral Benzedrine Molecules Interacting With Third Dopamine Receptor.

  2016cites this paper
• In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors

  2016cites this paper
• ATM kinase: Much more than a DNA damage responsive protein.

  2016cites this paper
• The Role of DNA Repair in the Evolution of Vertebrate Longevity

  2016cites this paper
• Inhibition of Poly(ADP-Ribose) Polymerase by Nucleic Acid Metabolite 7-Methylguanine

  2016cites this paper
• PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention.

  2016cites this paper
• Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

  2016cites this paper
• Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin

  2015cites this paper
• Fragment based Design , Docking and Biological Evaluation to Identify Novel PARP 1 Inhibitors and their Role in Cancer

  2015cites this paper
• New Aryl Derivatives of Acridine with Poly ( ADP-Ribose ) Polymerase 1 Inhibitory Activity : A Molecular Modeling Approach

  2015cites this paper
• Mechanistic overview of ADP-ribosylation reactions.

  2015cites this paper
• Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.

  2015cites this paper
• The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity

  2015cites this paper
• Comparative structural analysis of the putative mono-ADP-ribosyltransferases of the ARTD/PARP family.

  2015cites this paper
• Endogenous ADP-Ribosylation

  2015cites this paper
• Identification and Functional Characterizations of N-Terminal α-N-Methylation and Phosphorylation of Serine 461 in Human Poly(ADP-ribose) Polymerase 3.

  2015cites this paper
• PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases.

  2015cites this paper
• Discovery of the PARP Superfamily and Focus on the Lesser Exhibited But Not Lesser Talented Members

  2015cites this paper
• Structural Basis for Lack of ADP-ribosyltransferase Activity in Poly(ADP-ribose) Polymerase-13/Zinc Finger Antiviral Protein*

  2015cites this paper
• Synthesen von NAD + -Analoga und ihre Anwendungen

  2015influential citation
• Role of PARP-1 in prostate cancer.

  2015cites this paper
• 5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly(ADP-Ribose)Polymerases (PARPs).

  2015cites this paper
• "Clickable" chain terminator NAD + analogs for labeling substrate proteins of poly(ADP-ribose) polymerases

  2015cites this paper
• The rise and fall of poly(ADP-ribose): An enzymatic perspective.

  2015cites this paper
• PARPs and ADP-Ribosylation: 50 Years … and Counting.

  2015cites this paper
• PARP-1 como regulador del ciclo celular

  2015cites this paper
• REGULATION OF ALC1'S SNF2 ATPASE: INTERPLAY BETWEEN THE SNF2 DOMAIN, THE MACRODOMAIN AND OTHER CONSERVED ELEMENTS

  2015cites this paper
• Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation.

  2015cites this paper
• Structure Based Design of PARP Inhibitors

  2015cites this paper
• Tankyrases: Structure, Function and Therapeutic Implications in Cancer

  2014cites this paper
• Role of PARP2 in DNA repair

  2014cites this paper
• In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine

  2014cites this paper
• The PARP1/ARTD1-Mediated Poly-ADP-Ribosylation and DNA Damage Repair in B Cell Diversification

  2014cites this paper
• Poly(ADP-Ribose)Polymerase Activity Controls Plant Growth by Promoting Leaf Cell Number

  2014cites this paper
• Targeting poly(ADP-ribose)polymerase1 in neurological diseases: A promising trove for new pharmacological interventions to enter clinical translation.

  2014cites this paper
• Suicidal cross-linking of PARP-1 to AP site intermediates in cells undergoing base excision repair

  2014influential citation
• Recognition of mono-ADP ribosylated ARTD10 substrates by ARTD8 macrodomains and acetylation of ARTD10

  2014cites this paper
• A review on PARP1 inhibitors: Pharmacophore modeling, virtual and biological screening studies to identify novel PARP1 inhibitors.

  2014cites this paper
• Probing PARP1-inhibitor complexes for the development of novel inhibitors.

  2014cites this paper
• The antimitotic potential of PARP inhibitors, an unexplored therapeutic alternative.

  2014cites this paper
• Synthesis and degradation of poly(ADP-ribose) in plants.

  2014cites this paper
• Novel bacterial ADP-ribosylating toxins: structure and function

  2014cites this paper